Australia’s National Health and Medical Research Council opened a public consultation on Monday on draft advice that would keep puberty blockers as an option for some trans and gender diverse people under 18. Access through public services in Queensland and the Northern Territory remains restricted.
The draft says clinicians can consider blockers if a young person wants that care, has started puberty and has a gender that differs from the sex recorded for them at birth. Clinicians also need to assess whether the treatment is suitable. The council calls for a shared decision involving the young person, their parents or carers, and their clinicians. Its plain-language summary says that a young person need not already be in distress for care to be considered.
Queensland’s direction bars public hospitals and health services from starting blockers or gender-affirming hormones for new patients under 18 for gender dysphoria. It allows treatment to continue for patients who were already receiving it and meet the direction’s criteria. The Northern Territory government says its public system does not provide those medicines for this care.
The council is taking submissions until 1pm Australian Eastern Daylight Time on 18 January 2027. It expects to seek public feedback on the wider draft guidelines, which will cover other aspects of care, by early 2028.




Printable Version









Reader's Comments
Be the first to leave a comment on this page!
Please log in to use this feature.